Article(electronic) SSRN
Translational Selenium Nanotherapeutics Counter-Acts Multiple Risk Factors to Improve Surgery-Induced Cognitive Impairment
In: CEJ-D-22-01987
Checking availability at your location
This article is also available at your library: |
electronic
print
Report Issue